Search research articles
Contact Us
Filters
Showing results (11-20 of 34) with videos related to
Page
of 4
Sort By:
Journal of Chromatography. B, Biomedical Sciences and Applications
|
March 28, 1998
Simple high-performance liquid chromatographic method for determination of losartan and E-3174 metabolite in human plasma, urine and dialysate
D Farthing, D Sica, I Fakhry, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis
|
January 1, 1994
Hormonal, blood pressure, and peritoneal transport response to short-term ACE inhibition
E B Ripley, T W Gehr, C W Kish, et al.
Clinical Pharmacology and Therapeutics
|
May 1, 1988
Furosemide pharmacokinetics and pharmacodynamics in renal transplantation
T W Gehr, D A Sica, C Brater, et al.
Clinical Pharmacokinetics
|
July 8, 2000
Pharmacokinetics and blood pressure response of losartan in end-stage renal disease
D A Sica, C E Halstenson, T W Gehr, et al.
Journal of Clinical Pharmacology
|
April 13, 2000
The pharmacokinetics and pharmacodynamics of losartan in continuous ambulatory peritoneal dialysis
A A Pedro, T W Gehr, D F Brophy, et al.
European Journal of Clinical Pharmacology
|
January 1, 1993
The pharmacokinetics and pharmacodynamics of fosinopril in haemodialysis patients
T W Gehr, D A Sica, D M Grasela, et al.
Pharmacotherapy
|
February 24, 2001
The pharmacokinetics of subcutaneous enoxaparin in end-stage renal disease
D F Brophy, L D Wazny, T W Gehr, et al.
Journal of Pharmaceutical Sciences
|
June 1, 1992
External-standard high-performance liquid chromatographic method for quantitative determination of furosemide in plasma by using solid-phase extraction and on-line elution
D Farthing, T Karnes, T W Gehr, et al.
International Journal of Clinical Pharmacology and Therapeutics
|
January 1, 1994
The effect of nonsteroidal agents (NSAIDs) on the pharmacokinetics and pharmacodynamics of metolazone
E B Ripley, T W Gehr, H Wallace, et al.
Pharmacotherapy
|
August 12, 2000
Cost-effectiveness of sevelamer versus calcium carbonate plus atorvastatin to reduce LDL in patients with chronic renal insufficiency with dyslipidemia and hyperphosphatemia
D F Brophy, J F Wallace, D T Kennedy, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 34) with videos related to
Sort By:
Page
of 4
Journal of Chromatography. B, Biomedical Sciences and Applications
|
March 28, 1998
Simple high-performance liquid chromatographic method for determination of losartan and E-3174 metabolite in human plasma, urine and dialysate
D Farthing, D Sica, I Fakhry, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis
|
January 1, 1994
Hormonal, blood pressure, and peritoneal transport response to short-term ACE inhibition
E B Ripley, T W Gehr, C W Kish, et al.
Clinical Pharmacology and Therapeutics
|
May 1, 1988
Furosemide pharmacokinetics and pharmacodynamics in renal transplantation
T W Gehr, D A Sica, C Brater, et al.
Clinical Pharmacokinetics
|
July 8, 2000
Pharmacokinetics and blood pressure response of losartan in end-stage renal disease
D A Sica, C E Halstenson, T W Gehr, et al.
Journal of Clinical Pharmacology
|
April 13, 2000
The pharmacokinetics and pharmacodynamics of losartan in continuous ambulatory peritoneal dialysis
A A Pedro, T W Gehr, D F Brophy, et al.
European Journal of Clinical Pharmacology
|
January 1, 1993
The pharmacokinetics and pharmacodynamics of fosinopril in haemodialysis patients
T W Gehr, D A Sica, D M Grasela, et al.
Pharmacotherapy
|
February 24, 2001
The pharmacokinetics of subcutaneous enoxaparin in end-stage renal disease
D F Brophy, L D Wazny, T W Gehr, et al.
Journal of Pharmaceutical Sciences
|
June 1, 1992
External-standard high-performance liquid chromatographic method for quantitative determination of furosemide in plasma by using solid-phase extraction and on-line elution
D Farthing, T Karnes, T W Gehr, et al.
International Journal of Clinical Pharmacology and Therapeutics
|
January 1, 1994
The effect of nonsteroidal agents (NSAIDs) on the pharmacokinetics and pharmacodynamics of metolazone
E B Ripley, T W Gehr, H Wallace, et al.
Pharmacotherapy
|
August 12, 2000
Cost-effectiveness of sevelamer versus calcium carbonate plus atorvastatin to reduce LDL in patients with chronic renal insufficiency with dyslipidemia and hyperphosphatemia
D F Brophy, J F Wallace, D T Kennedy, et al.
Page
of 4